Bavarian Nordic gets FDA approval for chikungunya vaccine
Bavarian Nordic (OTCPK:BVNRY) has received FDA approval for its vaccine Vimkunya for the prevention of chikungunya. The virus-like particle, or VLP, vaccine is approved for people aged 12 and older.
manilatimes5h
Mentor Nonprofit Leads Mentoring Advocates in Washington, D.C. for Annual Capitol Hill Day of Mentoring Advocacy
MENTOR's Chief Policy and Advocacy Officer Abbie Evans, led a pre-Summit half-day advocacy training on Jan. 28, immediately ...
Bavarian Nordic A/S: Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for commercial launch in the U.S. in the ...
Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention ...
Monocle17h
Car attack rattles first day of the Munich Security Conference
Monocle is in Munich with the latest on the “terror attack” as the Bavarian capital kicks off its high-stakes security ...
A driver plows into a demonstration in Munich, injuring 30 people
A driver drove a car into a labor union demonstration in central Munich on Thursday, injuring 30 people including children, ...